Skip to main content
Log in

Determination of drug metabolizing enzymes in needle biopsies of human liver

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

A micromethod is described for determination of the cytochrome P-450 content, demethylation rate of aminopyrine and p-nitroanisole, the activities of NADPH-cytochrome-c-reductase, pseudocholinesterase and glucose-6-phosphatase in homogenates of the small amount of human liver (about 20 mg) obtained by needle biopsy. 1 g of human liver contains 32–38 mg microsomal protein, much less than that present in rat liver (50–60 mg/g liver). The cytochrome P-450 content in normals was 10.8±2.6 nmoles/g liver wet weight (mean±1 S.D.). In severe hepatitis and cirrhosis the cytochrome P-450 content fell to 50% of the control value, whereas mild and moderate hepatitis did not produce any change. Similarly, only in seriously damaged livers were the demethylationrates of both substrates lowered. The activity of the NADPH-cytochrome-c-reductase was 1.88±0.51 micromoles/g liver × min and was not impaired even by severe liver damage. The activities of glucose-6-phosphatase and pseudocholinesterase also fell only in severe liver disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Ackermann, E., Heinrich, I.: Die Aktivität der N- und O- Demethylase in der Leber des Menschen. Biochem. Pharm.19, 327–342 (1970).

    Google Scholar 

  • —— Die Demethylierung von Aminophenazon und Codein in der Leber des Menschen. Biochem. Pharm.19, 1955–1973 (1970).

    Google Scholar 

  • Alexanderson, B., Price Evans, D.A., Sjöqvist, F.: Steadystate plasma levels of nortriptyline in twins: Influence of genetic factors and drug therapy. Brit. med. J.1969 IV, 764–768.

    Google Scholar 

  • Alvarez, A.P., Schilling, G., Levin, W., Kuntzman, R., Brand, L., Mark, L.: Cytochrome P-450 and b-5 in human liver microsomes. Clin. Pharm. and Therap.10, 655–659 (1969).

    Google Scholar 

  • Brodie, B.B.: Physiological disposition and chemical fate of thiobarbiturates in the body. Fed. Proc.11, 632–639 (1952).

    Google Scholar 

  • —— Axelrod, J.: The fate of antipyrine in man. J. Pharm. Baltimore98, 97–104 (1950).

    Google Scholar 

  • —— —— The fate of aminopyrine (pyramidon) in man and methods for the estimation of aminopyrine and its metabolites in biological material. J. Pharm. Baltimore99, 171–184 (1950).

    Google Scholar 

  • —— Bruns, J.J., Weiner, M.: Metabolism of drugs in subjects with Laennec's cirrhosis. Med. Exp.1, 290–292 (1959).

    Google Scholar 

  • Butler, T.C., Mahaffe, C., Wadell, C.W.: Phenobarbital: Studies of elimination, accumulation, tolerance and dosage schedules. J. Pharm. exp. Therap.111, 425–435 (1954)

    Google Scholar 

  • Darby, F.J., Newnes, W., Price Evans, D.A.: Human liver microsomal drug metabolism. Biochem. Pharm.19, 1514–1517 (1970).

    Google Scholar 

  • Greim, H.: Synthesesteigerung und Abbauhemmung bei der Vermehrung der mikrosomalen Cytochrome P-450 und b-5 durch Phenobarbital. Naunyn Schmiedebergs Arch. Pharmak.266, 261–275 (1970).

    Google Scholar 

  • Griffin, C.C., Waradekar, V.S., Tramp, B.F., Goldblatt, P.J., Stowell, R.E.: Studies on necrosis on mouse liver. Amer. J. Path.47, 833–850 (1965).

    Google Scholar 

  • Harper, A.E.: Glucose-6-phosphatase. In Bergemeyer: Methoden der enzymatischen Analyse. S. 788–792. Weinheim: Verlag Chemie 1962.

    Google Scholar 

  • Held, V., v. Oldershausen, H.F.: Zur Pharmakokinetik von Meprobamat bei chronischen Hepatopathien und Arzeneimittelsucht. Klin. Wschr.47, 78–80 (1969).

    Google Scholar 

  • —— —— Remmer, H.: Der Abbau von Pentobarbital bei Leberschäden. Klin. Wschr.48, 565–567 (1970).

    Google Scholar 

  • Heni, N., Remmer, H.: Die Wirkung von Tetrachlorkohlenstoff auf endoplasmatische Enzyme der Rattenleber. Arch. Toxicol.28, 1–11 (1971).

    Google Scholar 

  • Kommerell, B., Franken, F.H.: Über die Serumcholinesteraseaktivität bei Lebererkrankungen. Dtsch. med. Wschr.81, 1959–1961 (1956).

    Google Scholar 

  • Kunin, C., Anthony, M., Glazko, J., Finland, M.: Persistence of antibiotics in blood of patients with acute renal failure. II. Chloramphenicol and its metabolic products in the blood of patients with severe renal disease or hepatic cirrhosis. J. clin. Invest.38, 1498–1508 (1959).

    Google Scholar 

  • Levi, A.J., Sherlock, S., Walker, D.: Phenylbutazone and isoniazid metabolism in patients with liver disease in relation to previous drug therapy. Lancet1968 II, 1275–1279.

    Google Scholar 

  • Lowry, O.H., Rosebrough, N.J., Farr, A.L., Randal, R.J.: Protein measurement with the folin phenol reagent. J. biol. Chem.193, 265–275 (1951).

    Google Scholar 

  • Massey, V.: The microestimation of succinate and the extinction coefficient of cytochrome c. Biochim. Biophys. Acta34, 255–256 (1959).

    Google Scholar 

  • Nash, T.: The colorimetric estimation of formaldehyde by means of the Hantzsch reaction. Biochem. J.55, 416–421 (1953).

    Google Scholar 

  • Netter, K.J., Seidel, G.: An adaptively stimulated O-demethylating system in rat liver microsomes and its kinetic properties. J. Pharm. exp. Therap.146, 61–65 (1964).

    Google Scholar 

  • Omura, T., Sato, R.: The carbon monoxide — binding pigment of liver. J. biol. Chem.239, 2370–2378 (1964).

    Google Scholar 

  • Preisig, R.: Beurteilung der alkoholischen Zirrhose nach hämodynamischen und funktionellen Gesichtspunkten: Alcohol and the liver, p. 329–331. International Symposion, October 2–4, 1970 Freiburg, Germany. Stuttgart-New York: F.K. Schattauer Verlag 1971.

    Google Scholar 

  • Quinn, C.P., Axelrod, J., Brodie, B.B.: Species, strain, and sex differences in metabolism of hexobarbitone amidopyrine, antipyrine and aniline. Biochem. Pharm.1, 152–159 (1958).

    Google Scholar 

  • Raj, P., Nelson, E.B., Estabrook, R.W.: Studies on drug metabolism in human liver. Chemico-Biol. Interact.3, 303–304 (1971).

    Google Scholar 

  • Remmer, H.: Die Standardisierung des roten Blutfarbstoffs durch Hämiglobincyanid. II. Mitteilung. Arch. exper. Path. und Pharm.229, 450–462 (1956).

    Google Scholar 

  • -- Estabrook, R.W., Schenkman, J., Greim, H.: Induction of microsomal liver enzymes. In: Enzymatic oxidations of toxicants. North Carolina State University of Raleigh. Library of Congress. Catalog card Number 68–63 363 (1968) p. 65–88.

  • —— Hirschmann, J., Greiner, I.: Die Bedeutung von Kumulation und Elimination für die Dosierung von Phenytoin (Diphenylhydantoin). Dtsch. med. Wschr.94, 1265–1272 (1969).

    Google Scholar 

  • Schmidt, E., Schmidt, F.W., Wildhirt, E.: Ferment-aktivitätsbestimmungen in der menschlichen Leber. VI. Mitteilung. Klin. Wschr.37, 1221–1229 (1959).

    Google Scholar 

  • Schenkman, J.B., Frey, I., Remmer, H., Estabrook, R.W.: Sex differences in drug metabolism by rat liver microsomes. Molec. Pharm.3, 516–525 (1967).

    Google Scholar 

  • Schoene, B., Remmer, H.: to be published.

  • Thorgeirsson, S.S., Davies, D.S.: Kinetic studies of the N-demethylation of ethylmorphine by a cytochrome P-450 dependent system in human liver microsomes. Int. Sympos. on Drug metabolism. Skokloster, Sweden June 2–4 (1971).

  • Vesell, E.S., Page, J.G.: Genetic control of drug levels in man: phenylbutazone. Science159, 1479–1480 (1968).

    Google Scholar 

  • —— —— Genetic control of drug levels in man: antipyrine. Science161, 72–73 (1968).

    Google Scholar 

  • —— —— Passananti, G.Th.: Genetic and environmental factors affecting ethanol metabolism in man. Clin. Pharm. and Therap.12, 192–201 (1971).

    Google Scholar 

  • Weber, H.: Rasche und einfache Ultramikromethode zur Bestimmung der Serumcholinesterase. Dtsch. med. Wschr.91, 1927–1932 (1966).

    Google Scholar 

  • Williams, Ch.H., Kamin, H.: Microsomal triphosphopyridine nucleotide-cytochrome-c-reductase of liver. J. biol. Chem.237, 587–595 (1962).

    Google Scholar 

  • Williams, R.: Clinical implications of hepatic enzyme induction. 13th Meeting of the European Society for the Study of Drug Toxicity Berlin, Germany June 7–9 (1971).

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schoene, B., Fleischmann, R.A., Remmer, H. et al. Determination of drug metabolizing enzymes in needle biopsies of human liver. Eur J Clin Pharmacol 4, 65–73 (1972). https://doi.org/10.1007/BF00562499

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00562499

Key words

Navigation